Ann: Trading Halt, page-213

A 4 million dollar placement to institutional investors which 25% of that goes to pay Voight's salary for a year.

Were management deceiving us by saying they were cashed up to mid 2020?

Are they deceiving us by saying 'milestone payments are due'?

I am with ML173 on this one. They might have a solid science team, but their business management is atrocious. They are raising at the lowest of lows once again. The 'endgame' may be results, but long term and loyal shareholders still like to see a return on their investment while patiently waiting for those results. This company has not produced a return on investment for its shareholders for several years.

My patience is wearing extremely thin with this company.

'Royally shafted' is how I am feeling at this moment and I am sure I am not the only one.

We can only hope that one day we can get out of this mess with some decent coin in the bank and their science helps cancer sufferers. A 'win win' situation. At the moment the feeling is more about losing.....